Michael Largen

938 total citations
23 papers, 778 citations indexed

About

Michael Largen is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Materials Chemistry. According to data from OpenAlex, Michael Largen has authored 23 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Materials Chemistry. Recurrent topics in Michael Largen's work include Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Biochemical and Molecular Research (5 papers). Michael Largen is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Biochemical and Molecular Research (5 papers). Michael Largen collaborates with scholars based in United States. Michael Largen's co-authors include Benjamin A. Taylor, James D. Watson, Kathleen Kelly, H R Buckley, Nancy Strockbine, J D Watson, Keith P. W. J. McAdam, William L. Belser, CW Cotman and PT Kelly and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Michael Largen

23 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Largen United States 14 330 267 169 127 66 23 778
A. Adam France 15 360 1.1× 252 0.9× 171 1.0× 248 2.0× 73 1.1× 26 1.1k
Shozo Shoji Japan 19 636 1.9× 172 0.6× 169 1.0× 86 0.7× 60 0.9× 73 971
Satish Jindal United States 14 608 1.8× 360 1.3× 91 0.5× 128 1.0× 52 0.8× 20 916
A. A. Jacobs United States 18 266 0.8× 370 1.4× 113 0.7× 84 0.7× 92 1.4× 25 951
Carol A. King United States 9 447 1.4× 150 0.6× 70 0.4× 79 0.6× 63 1.0× 9 747
S. Swaminathan United States 11 446 1.4× 238 0.9× 205 1.2× 33 0.3× 72 1.1× 18 1.0k
Scott Winston United States 15 415 1.3× 119 0.4× 161 1.0× 176 1.4× 76 1.2× 26 828
T Y Liu United States 8 452 1.4× 160 0.6× 31 0.2× 82 0.6× 74 1.1× 8 796
Michael Manneberg Switzerland 13 453 1.4× 187 0.7× 53 0.3× 39 0.3× 68 1.0× 18 822
Vaughan Wittman United States 15 498 1.5× 261 1.0× 124 0.7× 85 0.7× 76 1.2× 17 951

Countries citing papers authored by Michael Largen

Since Specialization
Citations

This map shows the geographic impact of Michael Largen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Largen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Largen more than expected).

Fields of papers citing papers by Michael Largen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Largen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Largen. The network helps show where Michael Largen may publish in the future.

Co-authorship network of co-authors of Michael Largen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Largen. A scholar is included among the top collaborators of Michael Largen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Largen. Michael Largen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thammana, Pallaiah, et al.. (1992). Sequences of variable regions of a monoclonal antibody specific to the thyroid hormone, triiodo-L-thyronine. Molecular Immunology. 29(7-8). 1025–1028. 1 indexed citations
2.
Allard, W. Jeffrey, et al.. (1992). Antigen binding properties of highly purified bispecific antibodies. Molecular Immunology. 29(10). 1219–1227. 13 indexed citations
3.
Tannenbaum, Charles S. & Michael Largen. (1990). The correlation between specific protein synthesis and tumoricidal function in murine peritoneal macrophages. Cellular Immunology. 131(1). 52–66. 1 indexed citations
4.
Largen, Michael, et al.. (1988). Production and characterisation of monoclonal antibodies specific for staphylococcal enterotoxin B. Journal of Medical Microbiology. 27(4). 263–270. 18 indexed citations
5.
Tannenbaum, Charles S., et al.. (1987). Differential Protein Synthesis by Murine Peritoneal Macrophages Elicited by Various Stimuli. Journal of Leukocyte Biology. 41(6). 527–538. 13 indexed citations
6.
Largen, Michael & Charles S. Tannenbaum. (1986). LPS regulation of specific protein synthesis in murine peritoneal macrophages.. The Journal of Immunology. 136(3). 988–993. 20 indexed citations
7.
Strockbine, Nancy, Michael Largen, & H R Buckley. (1984). Production and characterization of three monoclonal antibodies to Candida albicans proteins. Infection and Immunity. 43(3). 1012–1018. 55 indexed citations
9.
Jackson, David E., Wai T. Wong, Michael Largen, & Gerald D. Shockman. (1984). Monoclonal antibodies to immunodeterminants of lipoteichoic acids. Infection and Immunity. 43(3). 800–803. 14 indexed citations
10.
Largen, Michael, et al.. (1983). Identification of multiple-molecular-weight forms of thymocyte comitogenic activity from the monocyte/macrophage cell line RAW 264.7. Cellular Immunology. 80(1). 84–96. 6 indexed citations
11.
Kelly, PT, CW Cotman, & Michael Largen. (1979). Cyclic AMP-stimulated protein kinases at brain synaptic junctions.. Journal of Biological Chemistry. 254(5). 1564–1575. 57 indexed citations
12.
Watson, J D, Michael Largen, & Keith P. W. J. McAdam. (1978). Genetic control of endotoxic responses in mice.. The Journal of Experimental Medicine. 147(1). 39–49. 71 indexed citations
13.
Watson, James D., Kathleen Kelly, Michael Largen, & Benjamin A. Taylor. (1978). The Genetic Mapping of a Defective Lps Response Gene in C3H/HeJ Mice. The Journal of Immunology. 120(2). 422–424. 226 indexed citations
14.
Largen, Michael & Stanley E. Mills. (1977). Immunochemical analysis of the anthranilate synthase-anthranilate 5-phosphoribosylpyrophosphate phosphoribosyltransferase aggregate of Escherichia coli. Biochemistry. 16(11). 2526–2532. 3 indexed citations
15.
Hankins, Charles N., Michael Largen, & Stanley E. Mills. (1976). Some Physical Characteristics of the Enzymes of l-Tryptophan Biosynthesis in Higher Plants. PLANT PHYSIOLOGY. 57(1). 101–104. 19 indexed citations
17.
Hankins, Charles N., Michael Largen, & Stanley E. Mills. (1975). A rapid spectrophotofluorometric assay for indoleglycerol phosphate synthase. Analytical Biochemistry. 69(2). 510–517. 14 indexed citations
18.
Largen, Michael & William L. Belser. (1975). Tryptophan biosynthetic pathway in the Enterobacteriaceae: some physical properties of the enzymes. Journal of Bacteriology. 121(1). 239–249. 25 indexed citations
19.
Largen, Michael & William L. Belser. (1973). THE APPARENT CONSERVATION OF THE INTERNAL LOW EFFICIENCY PROMOTER OF THE TRYPTOPHAN OPERONS OF SEVERAL SPECIES OF ENTEROBACTERIACEAE. Genetics. 75(1). 19–22. 16 indexed citations
20.
Largen, Michael, et al.. (1971). INITIATOR CONSTITUTIVE MUTANTS OF THE L-ARABINOSE OPERON (OIBAD) OF ESCHERICHIA COLI B/r. Genetics. 69(3). 289–302. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026